Mechanistically, RSL-induced ferroptosis enhanced the antitumor efficiency of anti-PD-1 treatment by increasing the repertoire and frequency of tumor neoantigen-specific CD8+ T cells. The gene discussed is PDCD1; the disease is neoplasm.